Concepedia

Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single centre case series

Justin Jui Yuan Yeo

The Journal of Laryngology & Otology · 2023 · 12 citations · 6 references

DOI

Abstract

Neoadjuvant tyrosine kinase inhibitors in locally advanced differentiated thyroid cancer can be effective in reducing primary tumour extent to potentially facilitate a more limited surgical resection for local disease control.

References

6

Increasing Incidence of Thyroid Cancer in the United States, 1973-2002

Louise Davies, H. Gilbert Welch · JAMA · 2006 · 3.3K citations

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

Marcia S. Brose, Christopher M. Nutting, Barbara Jarząb et al. · The Lancet · 2014 · 1.6K citations · Full text

, , +9

Are the Clinical and Pathological Features of Differentiated Thyroid Carcinoma Really Changed over the Last 35 Years? Study on 4187 Patients from a Single Italian Institution to Answer this Question

Rossella Elisei, Eleonora Molinaro, Laura Agate et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 224 citations · Full text

Tyrosine Kinase Inhibitor Therapy in Locally Advanced Differentiated Thyroid Cancer: A Case Report

Kirsten Stewart, Mark W. J. Strachan, Devraj Srinivasan et al. · European Thyroid Journal · 2019 · 38 citations · Full text

, , +21

Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system

Ji Min Oh, S Kalimuthu, Prakash Gangadaran et al. · Oncotarget · 2018 · 24 citations · Full text